Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
C-Rad AB Class B ( ($SE:CRAD.B) ) just unveiled an announcement.
C-RAD AB and iRT Systems GmbH have announced a partnership to enhance patient safety in radiotherapy by combining C-RAD’s surface-guided radiotherapy technology with iRT’s real-time beam verification system. This collaboration aims to provide clinical teams with advanced tools for automated workflows, quality assurance, and improved treatment fidelity, ultimately making radiation therapy safer and more efficient.
More about C-Rad AB Class B
C-RAD AB is a leader in advanced surface guided radiotherapy technology, offering products like Catalyst™ and Sentinel™ that focus on accurate dose delivery and patient safety in radiation therapy. The company uses high-speed 3D cameras and augmented reality to enhance patient setup and motion monitoring, ensuring efficient workflows and improved treatment accuracy without additional imaging doses.
YTD Price Performance: 19.67%
Average Trading Volume: 39,642
Technical Sentiment Signal: Buy
Current Market Cap: SEK1.21B
For detailed information about CRAD.B stock, go to TipRanks’ Stock Analysis page.